BioLineRx Ltd (BLRX)

Etorro trading 970x250
BioLineRx Ltd (BLRX) Logo

About BioLineRx Ltd

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040, a peptide for the treatment of solid tumors, hematological malignancies, and stem cell mobilization; AGI-134, an immuno-oncology agent in the development for solid tumors; and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of skin lesions. The company has collaboration agreement with MSD for the cancer immunotherapy field; MD Anderson Cancer Center to investigate the combination of BL-8040 with KEYTRUDA (pembrolizumab) in pancreatic cancer; and Genentech Inc. to investigate the combination of BL-8040 for solid tumors. BioLineRx Ltd. was founded in 2003 and is headquartered in Hevel Modi’in, Israel. Address: Modi?in Technology Park, Hevel Modi’in, Israel, 7177871

BioLineRx Ltd News and around…

Latest news about BioLineRx Ltd (BLRX) common stock and company :

BioLineRx Reports Third Quarter 2021 Financial Results and Provides Corporate Update
18 Nov, 2021 Yahoo! Finance

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended September 30, 2021 and provides a corporate update.

Earnings Scheduled For November 18, 2021
18 Nov, 2021 FinancialContent

Companies Reporting Before The Bell • Alibaba Group Holding (NYSE:BABA) is expected to report quarterly earnings at ...

BioLineRx to Report Third Quarter 2021 Results on November 18, 2021
12 Nov, 2021 Yahoo! Finance

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will release its unaudited financial results for the quarter ended September 30, 2021 on Thursday, November 18, 2021, before the US markets open.

Thursday Market Overview
04 Nov, 2021 FinancialContent

If you are an IBM shareholder you now own something new Kyndryl.

BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
04 Nov, 2021 Yahoo! Finance

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical Company focused on oncology, today announced an oral presentation and three poster presentations at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition, which is being held December 11-14, 2021 in Atlanta, GA, and virtually.

12 Health Care Stocks Moving In Friday's Pre-Market Session
22 Oct, 2021 FinancialContent

Gainers Nutriband (NASDAQ:NTRB) shares rose 15.52% to $6.72 during Friday's pre-market session. The market value of ...

Accelerating R&D Activities in Breast Cancer Therapy Market Fueling Optimism for Development of Advanced Treatments
14 Oct, 2021 FinancialContent
BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization
13 Oct, 2021 Yahoo! Finance

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today announced positive results from a pharmacoeconomic study evaluating the cost-effectiveness of using investigational drug Motixafortide as a primary stem cell mobilization (SCM) agent on top of granulocyte colony stimulating factor (G-CSF), versus G-CSF alone, in multiple myeloma patients undergoing autologous stem cell transplantation (ASCT). The study was performed by the Globa

11 Best Stocks for Long Term Growth
06 Oct, 2021 Yahoo! Finance

In this article, we discuss the 11 best stocks for long-term growth. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Stocks for Long Term Growth. As the economy recovers post COVID-19, many investors see the surge in consumer spending and the expansion of the digital economy […]

A Weak Week
10 Sep, 2021 FinancialContent

Chinese car-maker Nio appears to have been able to weather the Beijing crackdown on foreign listed firms better than later entrants.

BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update
18 Aug, 2021 Yahoo! Finance

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended June 30, 2021 and provides a corporate update.

Earnings Scheduled For August 18, 2021
18 Aug, 2021 FinancialContent

Companies Reporting Before The Bell • Digital Ally (NASDAQ:DGLY) is likely to report quarterly loss at $0.04 per share ...

Friday the Thirteenth
13 Aug, 2021 FinancialContent

The stock week in points eastward was mixed. The USA markets face a bear correction.

BioLineRx to Report Second Quarter 2021 Results on August 18, 2021
12 Aug, 2021 Yahoo! Finance

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will release its unaudited financial results for the quarter ended June 30, 2021 on Wednesday, August 18, 2021, before the US markets open.

Joblessness Surprise
23 Jul, 2021 FinancialContent

Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.

“Claw-Back” day
20 Jul, 2021 FinancialContent

The rally was just as irrational as the selloff.

Delta Defeats Bulls
20 Jul, 2021 FinancialContent

Stocks tended to crash without rhyme or reason.

Weak Week
16 Jul, 2021 FinancialContent

Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism.

First Week of September 17th Options Trading For BioLineRx
16 Jul, 2021 FinancialContent

Investors in BioLineRx Ltd (BLRX) saw new options begin trading this week, for the September 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BLRX options chain for the new September 17th contracts and identified the following call contract of particular interest.

Powell Talks Some More
15 Jul, 2021 FinancialContent

Another day, another sell-off.

Dialing For Stocks
14 Jul, 2021 FinancialContent

Thanks to Fed Chairman Powell, markets brushed off worrying about inflation today. 

12 Health Care Stocks Moving In Friday's After-Market Session
09 Jul, 2021 FinancialContent

Gainers Delcath Systems (NASDAQ:DCTH) stock increased by 8.87% to $11.9 during Friday's after-market session. This security traded ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
06 Jul, 2021 FinancialContent

Gainers Opiant Pharmaceuticals (NASDAQ:OPNT) stock increased by 35.04% to $17.9 during Tuesday's after-market session. Opiant ...

56 Biggest Movers From Friday
06 Jul, 2021 FinancialContent

Gainers Sequential Brands Group, Inc. (NASDAQ: SQBG) jumped 89.2% to settle at $15.70. Eco Wave Power Global AB (NASDAQ: WAVE) ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
01 Jul, 2021 FinancialContent

Gainers Alterity Therapeutics (NASDAQ:ATHE) shares moved upwards by 60.76% to $2.09 during Thursday's pre-market ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
01 Jul, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We're starting the day off with a deep dive into the biggest pre-market stock movers for Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner

20 Stocks Moving in Thursday's Pre-Market Session
01 Jul, 2021 FinancialContent

Gainers Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
30 Jun, 2021 FinancialContent

Gainers BioLine Rx (NASDAQ:BLRX) stock increased by 31.67% to $3.7 during Wednesday's after-market session. This security traded at ...

Is Bioline RX Ltd (BLRX) A Good Stock To Buy?
30 Jun, 2021 Yahoo! Finance

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]

Wednesday Is A Normal Day
23 Jun, 2021 FinancialContent

Meme stocks Gamestop and Torchlight Energy both did share sales to cash in on their share price rises.

BioLineRx Ltd (BLRX) is a NASDAQ Common Stock listed in , ,

970x250